NCT Number: NCT07398833
Many studies have examined the effects of transcranial alternating current stimulation (tACS) on working memory, showing that low-intensity stimulation can enhance cognitive performance by modulating neuronal activity, particularly in the frontal cortex and the parietal lobule. Specific frequencies, such as the gamma frequency, have demonstrated beneficial effects on memory under high cognitive load. However, tACS has technical limitations, including uncomfortable sensations and uneven diffusion of electrical currents within the brain, which restrict its effectiveness in deeper brain regions.
Transcranial alternating magnetic stimulation (tAMS) is emerging as a potentially more precise and comfortable method. Unlike tACS, tAMS uses magnetic fields that penetrate more deeply into the brain and provide a more homogeneous distribution of induced electrical currents, allowing for more targeted stimulation. This study compares the effects of tACS and tAMS on working memory, with the hypothesis that tAMS will offer additional advantages in terms of comfort and efficacy. Cognitive performance will be assessed using working memory tasks, along with EEG signals to analyze neuronal modulations. The objective is to demonstrate that tAMS more effectively reaches deep brain regions and improves cognitive functions.
Trial opening soon.
Get Notified18 year–50 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non inclusion Criteria:
The experimental session lasts 2 hours and 30 minutes and includes four phases: Time 0, dedicated to training and adjustment of task difficulty, followed by Time 1, Time 2, and Time 3, corresponding respectively to assessments of working memory performance before, during, and after exposure to stimulation. Each phase includes blocks of the Sternberg task, for a total of 180 trials per session. Each block lasts 10 minutes.
The experimental session lasts 2 hours and 30 minutes and includes four time points: Time 0, dedicated to training and adjustment of task difficulty, followed by Time 1, Time 2, and Time 3, corresponding respectively to assessments of working memory performance before, during, and after exposure to stimulation. Each time point includes blocks of the Sternberg task, for a total of 180 trials per session. Each block lasts 10 minutes.
The experimental session lasts 2 hours and 30 minutes and includes four time points: Time 0, dedicated to training and adjustment of task difficulty, followed by Time 1, Time 2, and Time 3, corresponding respectively to assessments of working memory performance before, during, and after exposure to sham stimulation. Each time point includes blocks of the Sternberg task, for a total of 180 trials per session. Each block lasts 10 minutes.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
During each trial, participants memorize a sequence of eight letters presented sequentially. They are then shown a probe letter displayed in blue and must indicate whether this letter was part of the memorized sequence. Participant performance will be evaluated based on two behavioral measures: accuracy (proportions of correct and incorrect responses) and reaction time in milliseconds.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Absolute power of EEG frequency bands will be measured using power spectral density analysis to quantify the energy within each frequency band associated with working memory.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Relative power of EEG frequency bands will be calculated as the proportion of power in each frequency band relative to the total EEG signal power.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Mean frequency of the EEG signal will be calculated from the power spectral density to characterize frequency distribution related to working memory processes.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Median frequency of the EEG signal will be derived from the power spectral density as an indicator of the central tendency of EEG frequency content.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Peak power frequency of the EEG signal will be identified as the frequency at which maximum power occurs.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Recurrence rate derived from recurrence quantification analysis will be used to quantify the proportion of recurrent patterns in the EEG signal.
Time frame: Baseline (Day 1, before exposure), periprocedural (Day 1, during exposure), and post-intervention (Day 1, immediately after exposure)
Determinism derived from recurrence quantification analysis will be used to assess the temporal organization and regularity of EEG signal dynamics.
Time frame: Baseline (Day 1, before exposure)
Score from the Multidimensional Fatigue Inventory (MFI-20) will be used to assess fatigue.
The Multidimensional Fatigue Inventory is a self-reported questionnaire with total scores ranging from 20 to 100. Higher scores reflect higher levels of fatigue.
Time frame: Baseline (Day 1, before exposure)
Score from the State-Trait Anxiety Inventory (STAI) will be used to assess anxiety.
The State-Trait Anxiety Inventory is a self-reported questionnaire with scores ranging from 20 to 80. Higher scores reflect higher levels of anxiety.
Clinique Beau Soleil
Other
Acronym: MEMOCHAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737496
Healthy
Changsha, Hunan, China
View Trial DetailsNCT07727785
Healthy
Biberach, Germany
View Trial DetailsNCT07725809
Body Weight, Healthy
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07678567
Alcohol Use Disorder, Alcohol-Induced Disorders
Louisville, Kentucky, United States
View Trial Details